Amicus Therapeutics Stock Market Value
| FOLD Stock | USD 14.29 0.02 0.14% |
| Symbol | Amicus |
Will Biotechnology sector continue expanding? Could Amicus diversify its offerings? Factors like these will boost the valuation of Amicus Therapeutics. Market participants price Amicus higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Amicus Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.04) | Revenue Per Share | Quarterly Revenue Growth 0.195 | Return On Assets | Return On Equity |
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Amicus Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Amicus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amicus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amicus Therapeutics.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Amicus Therapeutics on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Amicus Therapeutics or generate 0.0% return on investment in Amicus Therapeutics over 90 days. Amicus Therapeutics is related to or competes with Ideaya Biosciences, Scholar Rock, Adaptive Biotechnologies, Arcutis Biotherapeutics, Mineralys Therapeutics, Kiniksa Pharmaceuticals, and Tarsus Pharmaceuticals. Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rar... More
Amicus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amicus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amicus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.15 | |||
| Information Ratio | 0.2014 | |||
| Maximum Drawdown | 30.77 | |||
| Value At Risk | (1.31) | |||
| Potential Upside | 3.45 |
Amicus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amicus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amicus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Amicus Therapeutics historical prices to predict the future Amicus Therapeutics' volatility.| Risk Adjusted Performance | 0.1657 | |||
| Jensen Alpha | 0.8247 | |||
| Total Risk Alpha | 0.5662 | |||
| Sortino Ratio | 0.6883 | |||
| Treynor Ratio | 2.19 |
Amicus Therapeutics January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1657 | |||
| Market Risk Adjusted Performance | 2.2 | |||
| Mean Deviation | 1.59 | |||
| Downside Deviation | 1.15 | |||
| Coefficient Of Variation | 460.86 | |||
| Standard Deviation | 3.94 | |||
| Variance | 15.51 | |||
| Information Ratio | 0.2014 | |||
| Jensen Alpha | 0.8247 | |||
| Total Risk Alpha | 0.5662 | |||
| Sortino Ratio | 0.6883 | |||
| Treynor Ratio | 2.19 | |||
| Maximum Drawdown | 30.77 | |||
| Value At Risk | (1.31) | |||
| Potential Upside | 3.45 | |||
| Downside Variance | 1.33 | |||
| Semi Variance | (0.23) | |||
| Expected Short fall | (2.15) | |||
| Skewness | 6.59 | |||
| Kurtosis | 49.09 |
Amicus Therapeutics Backtested Returns
Amicus Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Amicus Therapeutics secures Sharpe Ratio (or Efficiency) of 0.21, which signifies that the company had a 0.21 % return per unit of risk over the last 3 months. By analyzing Amicus Therapeutics' technical indicators, you can evaluate if the expected return of 0.87% is justified by implied risk. Please makes use of Amicus Therapeutics' Risk Adjusted Performance of 0.1657, coefficient of variation of 460.86, and Mean Deviation of 1.59 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Amicus Therapeutics holds a performance score of 16. The firm shows a Beta (market volatility) of 0.39, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amicus Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amicus Therapeutics is expected to be smaller as well. Please check Amicus Therapeutics' jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Amicus Therapeutics' price patterns will revert.
Auto-correlation | 0.45 |
Average predictability
Amicus Therapeutics has average predictability. Overlapping area represents the amount of predictability between Amicus Therapeutics time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amicus Therapeutics price movement. The serial correlation of 0.45 indicates that just about 45.0% of current Amicus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.45 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.98 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports:Check out Amicus Therapeutics Correlation, Amicus Therapeutics Volatility and Amicus Therapeutics Performance module to complement your research on Amicus Therapeutics. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Amicus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.